Pacira BioSciences Inc. (PCRX)
NASDAQ · Healthcare
Pacira BioSciences Inc. Revenue 2009–2025
Pacira BioSciences Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Pacira BioSciences Inc. revenue for the quarter ending March 31, 2026 was 177.4 M, a 5.00% increase year-over-year.
- Pacira BioSciences Inc. revenue for the twelve months ending March 31, 2026 was 706.9 M, a 4.32% increase year-over-year.
- Pacira BioSciences Inc. annual revenue for 2025 was 726.4 M, a 3.63% increase from 2024.
- Pacira BioSciences Inc. annual revenue for 2024 was 701.0 M, a 3.85% increase from 2023.
- Pacira BioSciences Inc. annual revenue for 2023 was 675.0 M, a 1.22% increase from 2022.
- Pacira BioSciences Inc. annual revenue for 2022 was 666.8 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Pacira BioSciences Inc. Earnings — FAQ
Pacira BioSciences Inc. (PCRX) earnings over the last 17 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see PCRX's earnings history?
The chart and table above show Pacira BioSciences Inc.'s earnings by year and by quarter, including the growth rate.